Showing results (11-20 of 382) with videos related to
Sort By:
Pageof 39
Lancet (London, England)|November 3, 1998
Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthmaO M Kon, B S Sihra, C H Compton, et al.American Journal of Respiratory and Critical Care Medicine|October 13, 2000
Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxinL N Khan, O M Kon, A J Macfarlane, et al.Allergy|August 12, 1999
Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challengeK Zeibecoglou, A J Macfarlane, S Ying, et al.The American Review of Respiratory Disease|November 1, 1991
Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitroC J Corrigan, P H Brown, N C Barnes, et al.The European Respiratory Journal|August 21, 2001
The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthmaO M Kon, B S Sihra, L C Loh, et al.New England and Regional Allergy Proceedings|January 1, 1985
Eosinophils: role in asthma, allergy and parasite immunityA B KayAllergy Proceedings : the Official Journal of Regional and State Allergy Societies|May 1, 1994
Immunosuppressive agents in chronic severe asthmaA B KayClinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 30, 2014
The early history of the eosinophilA B KayPageof 39